Imagine a world where superbugs laugh in the face of our best medicines, turning simple infections into deadly threats—now, a team of brilliant scientists is diving into the past to rewrite our medical future! But here's where it gets controversial: are we playing with fire by awakening microbes that have slumbered for millions of years, or is this our only shot at outsmarting antibiotic resistance?
In a fascinating journey through time, researchers at California Polytechnic State University (Cal Poly) are exploring ancient microorganisms to unearth groundbreaking antibiotics. Leading this effort is Katharine Watts, a biochemistry professor, alongside Frost Teacher-Scholar Postdoctoral Fellow Rachel Johnson. Their work centers on an extraordinary collection of microbial strains dating back roughly 25 to 40 million years—think of it as a time capsule from Earth's distant history.
This precious trove was generously donated by Cal Poly Professor Emeritus Raul Cano, who has a storied past. Cano collaborated with the entomologist George Poinar, the very scientist whose amber-encased insect discoveries inspired Michael Crichton's blockbuster novel Jurassic Park. Drawing from that legacy, Cano extracted these ancient bacteria from amber—a fossilized tree resin that acts like nature's perfect preservative—as well as from ocean floor sediments in the Gulf of Mexico. He even got creative, using ancient yeast from amber to brew a craft beer named 'Fossil Fuels,' showcasing how these relics can bridge science and everyday wonder.
Stored at a chilly minus 80 degrees Celsius (that's about minus 112 degrees Fahrenheit), over 40 bacterial strains from amber are kept ready for study. The team cultivates them near room temperature using nutrients typical for modern lab bacteria, allowing ongoing experiments. It's surreal to think these tiny survivors have remained viable across eons, offering a rare glimpse into a world before human civilization.
The Bailey College of Science and Mathematics researchers are thrilled by this opportunity. 'It's extremely exciting to have this rare chance to work with a treasure trove of ancient bacteria, which could be very different from those living in the modern environment,' Watts explains. Their mission? To screen these ancient strains for potential antibiotic production and decode their genetics to understand how they create these compounds.
To put it simply for beginners: antibiotics are like tiny molecular warriors produced by bacteria to fend off rivals. In medicine, we repurpose them to battle infections in humans. Watts and Johnson are hunting for new ones because the ones we have are losing their edge against antibiotic-resistant pathogens—bacteria that have evolved defenses against our drugs. This resistance turns treatable illnesses, like pneumonia, urinary tract infections, sepsis, skin inflammation, and foodborne diseases, into nightmares. For example, imagine a cut that won't heal because the bacteria causing it shrugs off standard treatments—scary, right?
By examining these underexplored ancient microbes, the team hopes to find fresh molecules that can outmaneuver today's tough bugs. But here's the part most people miss: this isn't just about new drugs; it's also about unraveling the mysteries of resistance itself. 'We're also testing these ancient microbes for their ability to survive modern antibiotic compounds,' Johnson shares. 'Through these screenings, we can go back in history and ask, "What were they resistant to back then?"' It's like detective work, piecing together how resistance developed over millennia.
So far, they've successfully cultured over 30 microbes and tested their compounds on safe lab bacteria that mimic real pathogens. Excitingly, they've pinpointed seven strains showing antibacterial activity—meaning they produce substances that can kill or inhibit harmful bacteria. However, the exact chemical makeup of these potential antibiotics remains to be fully analyzed. On another front, one strain demonstrated resistance to apramycin, an antibiotic commonly used in veterinary medicine for animal infections.
This resistance is intriguing. Bacteria often protect themselves from the antibiotics they make, so this strain might produce apramycin or something similar. Alternatively, it could have developed resistance through other evolutionary paths. Genetic studies will reveal the structures of these compounds and shed light on resistance mechanisms, potentially guiding future drug designs. And this is the part most people miss: understanding resistance isn't just defensive—it's a proactive way to stay ahead in the arms race against bacteria.
The roots of this project trace back decades. Cano, inspired by Poinar's amber fossils, isolated microbes from bee guts and soil preserved in amber, as chronicled in a 2009 WIRED magazine piece. In a groundbreaking 1993 study, Cano and Poinar teamed up to extract DNA from a 125-million-year-old weevil trapped in Lebanese amber. These efforts highlight how ancient DNA can unlock secrets of the past.
While the Cal Poly team is still in the discovery phase—predicting molecule types from genetic sequences and studying how antibiotics disrupt bacterial processes—they're not yet designing drugs. That step would demand massive investments, industry collaborations, and more research. Nevertheless, their findings could inspire new antibiotic frameworks and insights into resistance evolution.
Students involved are equally enthralled. 'Working with bacteria strains from millions of years ago is surreal,' says Safiya Rufino, a microbiology major and BEACoN Research Scholar. 'These bacteria samples have lived during a time we can only know through carbon dating. It also makes me wonder how it would be to one day be revived millions of years in the future, how would I react, would I still be able to function as I once did, as these bacteria are able to?' And Kaitlyn Calligan, another microbiology major and scholar, adds, 'It's really fun to have so many various strains of bacteria at our disposal. They include bright yellow, pink, matte white, or have interesting colony formations. Researching them truly is never boring.'
As we stand on the brink of this microbial time travel, one can't help but ponder the controversies. Could reviving ancient bacteria accidentally unleash pathogens adapted to a world without modern threats? Is it ethical to tamper with life forms that have been dormant for eons, potentially altering ecosystems we barely understand? And this is the part most people miss: what if these ancient strains hold clues not just to curing diseases, but to broader questions about evolution and adaptation?
What do you think? Should we embrace this bold exploration of the past to combat future pandemics, or is it risky science fiction that might backfire? Do you believe ancient microbes are our hidden heroes against superbugs, or could they pose unforeseen dangers? Share your thoughts in the comments—agreement or disagreement welcome—we're all in this together!
Citation: Scientists look to ancient microbes to discover the antibiotics of the future (2025, November 13) retrieved 13 November 2025 from https://phys.org/news/2025-11-scientists-ancient-microbes-antibiotics-future.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
